OTHER PUBLICATIONS

This living guideline from the World Health Organization (WHO) incorporates a new recommendation on molnupiravir for covid-19 and updates existing recommendations. The GDG typically evaluates a therapy when WHO judges sufficient evidence is available to make a recommendation.